The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription - PubMed (original) (raw)
Comparative Study
The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription
T Chong et al. J Virol. 1991 Nov.
Abstract
The enhancer of human papillomavirus type 16 (HPV-16) is considered to be specific for epithelial cells, in particular for cervical carcinoma-derived cell lines. We reexamined this hypothesis with the complete enhancer as well as nonoverlapping subclones and found all clones to be active in epithelial cell lines derived from the epidermis and from carcinomas of the cervix, mammary gland, and colon, but inactive in fibroblast, lymphoma, and embryonal carcinoma cells. Although the virus infects only human mucosal epithelia, enhancer activity was independent of the exact type or of the species of origin of the transfected epithelial cell. In spite of epithelial cell specificity, we found that the activity of the HPV-16 enhancer varied strongly from a cytomegalovirus enhancer and the simian virus 40 enhancer in a cell line-dependent manner. This suggests varying quantitative contributions of enhancer elements rather than regulation by an all-or-none switch. Cell type specificity was maintained by a 91-bp subclone of the 400-bp enhancer. Most of the enhancer activity of this fragment was eliminated by alternative mutations in binding sites for the ubiquitous factors AP-1, nuclear factor 1 (NF1), or TEF-2. These three types of factors bind this 91-bp enhancer without cooperation, although activation appears to be synergistic. Outside the 91-bp fragment, a motif typical for papillomavirus enhancers, namely an octamerlike sequence flanked by an NF1-binding site, contributes to enhancer function, as the activity was strongly reduced upon its deletion. In HPV-16, this motif is bound by the oct-1 factor as well as by a probably novel factor, NFA, whereas a related motif of HPV-11 is recognized only by NFA. On examination, none of the five types of transcription factors involved in HPV enhancer activation was restricted to epithelial cells, but NF1, AP-1, and oct-1 were present in higher concentration in HeLa cells than in fibroblasts. Only NF1 showed some qualitative cell type-specific differences. We propose that the epithelial specificity of the HPV-16 enhancer is brought about via binding sites for supposed ubiquitous transcription factors. The mechanism of this activation apparently involves synergism between factors that vary in concentration and may include cell-specific functional differences residing outside the DNA-binding domain of these factors.
Similar articles
- Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16.
Apt D, Chong T, Liu Y, Bernard HU. Apt D, et al. J Virol. 1993 Aug;67(8):4455-63. doi: 10.1128/JVI.67.8.4455-4463.1993. J Virol. 1993. PMID: 8392590 Free PMC article. - trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M, Lace MJ, Yamakawa Y, Kono M, Anson J, Ishiji T, Parkkinen S, Wicker N, Valentine ME, Davidson I, et al. Ushikai M, et al. J Virol. 1994 Oct;68(10):6655-66. doi: 10.1128/JVI.68.10.6655-6666.1994. J Virol. 1994. PMID: 8083999 Free PMC article. - Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner.
Apt D, Liu Y, Bernard HU. Apt D, et al. Nucleic Acids Res. 1994 Sep 25;22(19):3825-33. doi: 10.1093/nar/22.19.3825. Nucleic Acids Res. 1994. PMID: 7937100 Free PMC article.
Cited by
- Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region.
García-Vallvé S, Iglesias-Rozas JR, Alonso A, Bravo IG. García-Vallvé S, et al. BMC Evol Biol. 2006 Mar 9;6:20. doi: 10.1186/1471-2148-6-20. BMC Evol Biol. 2006. PMID: 16526953 Free PMC article. - Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K, Hoppe-Seyler F. Butz K, et al. J Virol. 1993 Nov;67(11):6476-86. doi: 10.1128/JVI.67.11.6476-6486.1993. J Virol. 1993. PMID: 8411351 Free PMC article. - Replication of JC Virus DNA in the G144 Oligodendrocyte Cell Line Is Dependent Upon Akt.
Peterson JN, Lin B, Shin J, Phelan PJ, Tsichlis P, Schwob JE, Bullock PA. Peterson JN, et al. J Virol. 2017 Sep 27;91(20):e00735-17. doi: 10.1128/JVI.00735-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768870 Free PMC article. - Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T, Lace MJ, Parkkinen S, Anderson RD, Haugen TH, Cripe TP, Xiao JH, Davidson I, Chambon P, Turek LP. Ishiji T, et al. EMBO J. 1992 Jun;11(6):2271-81. doi: 10.1002/j.1460-2075.1992.tb05286.x. EMBO J. 1992. PMID: 1318197 Free PMC article. - Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W, Huang Z, Tan SH, O'Connor MJ, Bernard HU. Stünkel W, et al. J Virol. 2000 Mar;74(6):2489-501. doi: 10.1128/jvi.74.6.2489-2501.2000. J Virol. 2000. PMID: 10684263 Free PMC article.
References
- Nucleic Acids Res. 1991 Jan 25;19(2):237-42 - PubMed
- Science. 1980 Sep 19;209(4463):1422-7 - PubMed
- J Gen Virol. 1990 Nov;71 ( Pt 11):2699-707 - PubMed
- J Virol. 1990 Nov;64(11):5577-84 - PubMed
- J Virol. 1990 Nov;64(11):5420-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous